A majority of human studies with metabolic dysfunction have shown that lower circulating levels of irisin are associated with obesity [10,12] and T2D [11,23,24,25,26,27,28]. This evidence concerns the gene FNDC5 and obesity due to melanocortin 4 receptor deficiency.